131 related articles for article (PubMed ID: 27488323)
1. Significance of BMI1 and FSCN1 expression in colorectal cancer.
Alajez NM
Saudi J Gastroenterol; 2016; 22(4):288-93. PubMed ID: 27488323
[TBL] [Abstract][Full Text] [Related]
2. Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.
Alajez NM
PLoS One; 2016; 11(12):e0167455. PubMed ID: 27935967
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑663 suppresses the proliferation and invasion of colorectal cancer cells by directly targeting FSCN1.
Yu S; Xie H; Zhang J; Wang D; Song Y; Zhang S; Zheng S; Wang J
Mol Med Rep; 2017 Dec; 16(6):9707-9714. PubMed ID: 29039557
[TBL] [Abstract][Full Text] [Related]
4. High expression of MMP19 is associated with poor prognosis in patients with colorectal cancer.
Chen Z; Wu G; Ye F; Chen G; Fan Q; Dong H; Zhu X; Wu C
BMC Cancer; 2019 May; 19(1):448. PubMed ID: 31088409
[TBL] [Abstract][Full Text] [Related]
5. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival.
Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D
PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
7. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data.
Kim E; Jung S; Park WS; Lee JH; Shin R; Heo SC; Choe EK; Lee JH; Kim K; Chai YJ
BMC Cancer; 2019 Apr; 19(1):302. PubMed ID: 30943948
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
[TBL] [Abstract][Full Text] [Related]
10. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
[TBL] [Abstract][Full Text] [Related]
11. CBX8 and CD96 Are Important Prognostic Biomarkers of Colorectal Cancer.
Song X; Tang T; Li C; Liu X; Zhou L
Med Sci Monit; 2018 Nov; 24():7820-7827. PubMed ID: 30383736
[TBL] [Abstract][Full Text] [Related]
12. Combined aberrant expression of Bmi1 and EZH2 is predictive of poor prognosis in glioma patients.
Wu Z; Wang Q; Wang L; Li G; Liu H; Fan F; Li Z; Li Y; Tu Y
J Neurol Sci; 2013 Dec; 335(1-2):191-6. PubMed ID: 24139839
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer.
Li Y; Gao Y; Xu Y; Ma H; Yang M
Growth Factors; 2015; 33(4):267-74. PubMed ID: 26359764
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.
Hashimoto Y; Skacel M; Lavery IC; Mukherjee AL; Casey G; Adams JC
BMC Cancer; 2006 Oct; 6():241. PubMed ID: 17029629
[TBL] [Abstract][Full Text] [Related]
15. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance.
Jantscheff P; Terracciano L; Lowy A; Glatz-Krieger K; Grunert F; Micheel B; Brümmer J; Laffer U; Metzger U; Herrmann R; Rochlitz C
J Clin Oncol; 2003 Oct; 21(19):3638-46. PubMed ID: 14512395
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target.
Ye L; Lin ST; Mi YS; Liu Y; Ma Y; Sun HM; Peng ZH; Fan JW
Tumour Biol; 2016 Nov; 37(11):14585-14594. PubMed ID: 27614686
[TBL] [Abstract][Full Text] [Related]
17. High Expression of Both Resistin and Fascin-1 Predicts a Poor Prognosis in Patients with Colorectal Cancer.
Wang CQ; Wang Y; Huang BF; Tang CH; Du Z; Zeng Y; Wang Q; Shao JK; Jin LL
Biomed Res Int; 2020; 2020():8753175. PubMed ID: 32420377
[TBL] [Abstract][Full Text] [Related]
18. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of FSCN1 in non-small cell lung cancer.
Luo A; Yin Y; Li X; Xu H; Mei Q; Feng D
Biomed Pharmacother; 2015 Jul; 73():75-9. PubMed ID: 26211585
[TBL] [Abstract][Full Text] [Related]
20. MMP14 predicts a poor prognosis in patients with colorectal cancer.
Cui G; Cai F; Ding Z; Gao L
Hum Pathol; 2019 Jan; 83():36-42. PubMed ID: 30120968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
